By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

VistaGen Therapeutics, Inc. 

384 Oyster Point Boulevard
Suite 8
South San Francisco  California  94080  U.S.A.
Phone: 650-244-9990 Fax: 650-244-9979


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For Canadian Patent Further Expanding Stem Cell Technology Platform 8/19/2014 11:35:13 AM
VistaGen Therapeutics, Inc. Announces Reverse Stock Split 8/14/2014 9:43:32 AM
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For Canadian Patent Expanding Stem Cell Technology Platform 6/16/2014 11:04:33 AM
VistaGen Therapeutics, Inc. Joins HESI's Cardiac Safety Committee And Working Groups 5/23/2014 9:27:29 AM
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For U.S. Patent Expanding Stem Cell Technology Platform For Drug Rescue And Regenerative Medicine 4/23/2014 8:54:51 AM
VistaGen Therapeutics, Inc. Joins The Cardiac Safety Research Consortium 4/11/2014 10:15:35 AM
Autilion AG Invests $36 Million Into VistaGen Therapeutics, Inc. 6/28/2013 11:26:22 AM
VistaGen Therapeutics, Inc. Presents CardioSafe 3D™ and LiverSafe 3D™ Developments at International Society for Stem Cell Research's 11th Annual Meeting 6/18/2013 9:03:17 AM
VistaGen Therapeutics, Inc. and Duke University Publish Results on Production of Functional 3D Human Heart Tissue 5/7/2013 10:32:15 AM
VistaGen Therapeutics, Inc. Raises $36 Million 4/10/2013 7:21:28 AM
1234567
//-->